E. Rubeglio

557 total citations
20 papers, 440 citations indexed

About

E. Rubeglio is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, E. Rubeglio has authored 20 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 8 papers in Epidemiology and 4 papers in Pharmacology. Recurrent topics in E. Rubeglio's work include Antimicrobial Resistance in Staphylococcus (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Antifungal resistance and susceptibility (3 papers). E. Rubeglio is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Antifungal resistance and susceptibility (3 papers). E. Rubeglio collaborates with scholars based in Argentina, United States and Lebanon. E. Rubeglio's co-authors include Horacio Lopardo, Barbara E. Murray, Kavindra V. Singh, Eduardo López, Susana Devoto, Mabel Woloj, Larry K. Pickering, Thomas G. Cleary, S Grinstein and Shai Ashkenazi and has published in prestigious journals such as Cancer, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

E. Rubeglio

20 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Rubeglio Argentina 7 325 165 118 87 80 20 440
Joe Huong United States 7 277 0.9× 86 0.5× 95 0.8× 232 2.7× 86 1.1× 8 559
Daniela Barbarini Italy 12 191 0.6× 181 1.1× 183 1.6× 130 1.5× 136 1.7× 27 499
Marie‐Christine Fonkoua Cameroon 11 217 0.7× 71 0.4× 108 0.9× 110 1.3× 59 0.7× 21 440
M Mathur India 13 242 0.7× 68 0.4× 75 0.6× 63 0.7× 37 0.5× 41 488
H. Talsania United Kingdom 11 200 0.6× 50 0.3× 153 1.3× 95 1.1× 89 1.1× 15 435
J Barnishan United States 11 143 0.4× 65 0.4× 65 0.6× 114 1.3× 112 1.4× 13 421
Y J Lau Taiwan 10 117 0.4× 134 0.8× 57 0.5× 79 0.9× 115 1.4× 13 342
Harold G. Jensen United States 12 158 0.5× 91 0.6× 100 0.8× 55 0.6× 56 0.7× 25 718
Kikuyo Ogata Japan 13 262 0.8× 135 0.8× 101 0.9× 60 0.7× 21 0.3× 25 436
Chiara Catavitello Italy 10 131 0.4× 125 0.8× 75 0.6× 116 1.3× 34 0.4× 18 386

Countries citing papers authored by E. Rubeglio

Since Specialization
Citations

This map shows the geographic impact of E. Rubeglio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Rubeglio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Rubeglio more than expected).

Fields of papers citing papers by E. Rubeglio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Rubeglio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Rubeglio. The network helps show where E. Rubeglio may publish in the future.

Co-authorship network of co-authors of E. Rubeglio

This figure shows the co-authorship network connecting the top 25 collaborators of E. Rubeglio. A scholar is included among the top collaborators of E. Rubeglio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Rubeglio. E. Rubeglio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rubeglio, E., et al.. (2019). Molecular epidemiology of Aspergillus species and other moulds in respiratory samples from Argentinean patients with cystic fibrosis. Medical Mycology. 58(7). 867–873. 12 indexed citations
2.
Pola, Suresh, et al.. (2018). Prevalence of fungal colonization in cystic fibrosis: a retrospective study over 3 years in Buenos Aires, Argentina. International Journal of Infectious Diseases. 73. 279–280. 1 indexed citations
3.
Córdoba, Susana, et al.. (2010). Epidemiología de las fungemias en un hospital pediátrico de alta complejidad. Revista Iberoamericana de Micología. 27(4). 200–202. 5 indexed citations
5.
Rubeglio, E., et al.. (2007). Escherichia coli O157 H7: presencia en alimentos no cárnicos. 105(3). 193–194. 2 indexed citations
6.
Lopardo, Horacio, et al.. (2002). Value of Etest penicillin V and penicillin G strips for penicillin susceptibility testing of Neisseria meningitidis. Diagnostic Microbiology and Infectious Disease. 43(2). 119–121. 3 indexed citations
7.
Hernández, C, et al.. (1999). Bacteroides fragilis Group in Middle Ear Infections. Anaerobe. 5(3-4). 359–362. 2 indexed citations
8.
Matteo, Mario, et al.. (1999). Susceptibility of Veillonella spp. to Ten Different Antibiotics. Anaerobe. 5(3-4). 477–478. 3 indexed citations
9.
Lopardo, Horacio, et al.. (1995). Detection of high- and moderately high-level resistance to gentamicin and streptomycin in Enterococcus faecium by a disc diffusion method. Journal of Antimicrobial Chemotherapy. 36(1). 237–240. 1 indexed citations
10.
Lopardo, Horacio, et al.. (1995). Penicillin Resistance and Aminoglycoside-Penicillin Synergy in Enterococci. Chemotherapy. 41(3). 165–171. 6 indexed citations
11.
Lopardo, Horacio, et al.. (1995). Streptococcus pyogenes: vigilancia de su resistencia a los antibióticos en un hospital pediátrico. 4 indexed citations
12.
Lopardo, Horacio, et al.. (1993). Isolation of moderately penicillin-susceptible strains of Neisseria meningitidis in Argentina. Antimicrobial Agents and Chemotherapy. 37(8). 1728–1729. 14 indexed citations
13.
Murray, Barbara E., et al.. (1992). Intrahospital spread of a single gentamicin-resistant, beta-lactamase-producing strain of Enterococcus faecalis in Argentina. Antimicrobial Agents and Chemotherapy. 36(1). 230–232. 43 indexed citations
14.
López, Eduardo, Mario Díaz, Susana Devoto, et al.. (1991). Evidence of infection with organisms producing Shiga-like toxins in household contacts of children with the hemolytic uremic syndrome. The Pediatric Infectious Disease Journal. 10(1). 20–24. 29 indexed citations
15.
Murray, B E, Kavindra V. Singh, Sheldon M. Markowitz, et al.. (1991). Evidence for Clonal Spread of a Single Strain of  -Lactamase-Producing Enterococcus (Streptococcus) faecalis to Six Hospitals in Five States. The Journal of Infectious Diseases. 163(4). 780–785. 159 indexed citations
16.
Lopardo, Horacio, Lidia Casimir, C Hernández, & E. Rubeglio. (1990). Isolation of three strains of beta-lactamase-producingEnterococcus faecalis in Argentina. European Journal of Clinical Microbiology & Infectious Diseases. 9(6). 402–405. 11 indexed citations
17.
López, Eduardo, Mario Dı́az, S Grinstein, et al.. (1989). Hemolytic Uremic Syndrome and Diarrhea in Argentine Children: The Role of Shiga-like Toxins. The Journal of Infectious Diseases. 160(3). 469–475. 132 indexed citations
18.
Rubeglio, E., et al.. (1987). Evaluation of a rapid test for group A Streptococcus at a physician's office and hospital laboratory in Buenos Aires, Argentina.. PubMed. 6(8). 762–4. 4 indexed citations
19.
Valle, Mario, Jorge Braier, J. Wasserman, et al.. (1981). Infections in children with malignant disease in Argentina. Cancer. 47(5). 1023–1030. 2 indexed citations
20.
López, Eduardo, et al.. (1980). Cefotaxime therapy in children with serious infections associated with reduced host defense mechanisms. Journal of Antimicrobial Chemotherapy. 6(suppl A). 249–253. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026